Geode Capital Management, LLC Apellis Pharmaceuticals, Inc. Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
A detailed history of Geode Capital Management, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,810,526 shares of APLS stock, worth $61.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,810,526
Previous 1,787,917
1.26%
Holding current value
$61.6 Million
Previous $68.6 Million
23.87%
% of portfolio
0.0%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding APLS
# of Institutions
309Shares Held
115MCall Options Held
3.85MPut Options Held
1.09M-
Wellington Management Group LLP Boston, MA15.6MShares$529 Million0.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$404 Million14.88% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$378 Million4.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$334 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$197 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.74B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...